{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:57:58Z","timestamp":1789768678785,"version":"4.0.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,9]],"date-time":"2016-12-09T00:00:00Z","timestamp":1481241600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.ekir.2016.12.003","type":"journal-article","created":{"date-parts":[[2016,12,16]],"date-time":"2016-12-16T19:22:09Z","timestamp":1481916129000},"page":"470-480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Profiling of Plasma Metabolites Suggests Altered Mitochondrial Fuel Usage and Remodeling of Sphingolipid Metabolism in Individuals With Type\u00a02 Diabetes and Kidney Disease"],"prefix":"10.1016","volume":"2","author":[{"given":"Jian-Jun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujoy","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Kovalik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Ching","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Won","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subramaniam","family":"Tavintharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choon Nam","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee Fang","family":"Sum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Summers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Shyong","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Chi","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2016.12.003_bib1","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1038\/sj.ki.5000377","article-title":"Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: A global perspective","volume":"69","author":"Parving","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2016.12.003_bib2","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.2337\/dc14-1296","article-title":"Diabetic kidney disease: A report from an ADA Consensus Conference","volume":"37","author":"Tuttle","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ekir.2016.12.003_bib3","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","article-title":"Changes in diabetes-related complications in the United States, 1990\u20132010","volume":"370","author":"Gregg","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2016.12.003_bib4","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1053\/j.ajkd.2013.10.050","article-title":"Clinical challenges in diagnosis and management of diabetic kidney disease","volume":"63","author":"Stanton","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2016.12.003_bib5","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1161\/CIRCULATIONAHA.111.060368","article-title":"Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: Form and function","volume":"126","author":"Shah","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2016.12.003_bib6","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.2215\/CJN.11971113","article-title":"Serum metabolomic profiling and incident CKD among African Americans","volume":"9","author":"Yu","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2016.12.003_bib7","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1053\/j.ajkd.2013.10.048","article-title":"Markers of and risk factors for the development and progression of diabetic kidney disease","volume":"63","author":"Macisaac","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2016.12.003_bib8","first-page":"371","article-title":"Metabolomics and renal disease","volume":"24","author":"Rhee","year":"2015","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.ekir.2016.12.003_bib9","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1681\/ASN.2013020126","article-title":"Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease","volume":"24","author":"Sharma","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2016.12.003_bib10","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.jdiacomp.2015.06.016","article-title":"Metabolomic biomarkers in diabetic kidney diseases: A systematic review","volume":"29","author":"Zhang","year":"2015","journal-title":"J\u00a0Diabetes Complications"},{"key":"10.1016\/j.ekir.2016.12.003_bib11","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/ki.2013.497","article-title":"Uremic solutes and risk of end-stage renal disease in type 2 diabetes: Metabolomic study","volume":"85","author":"Niewczas","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2016.12.003_bib12","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00125-011-2339-6","article-title":"A\u00a0metabolomic study of low estimated GFR in non-proteinuric type 2 diabetes mellitus","volume":"55","author":"Ng","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.ekir.2016.12.003_bib13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1053\/j.ajkd.2012.01.014","article-title":"Serum metabolite concentrations and decreased GFR in the general population","volume":"60","author":"Goek","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2016.12.003_bib14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s11306-011-0343-y","article-title":"Sphingomyelin is associated with kidney disease in type 1 diabetes (the FinnDiane Study)","volume":"8","author":"Makinen","year":"2012","journal-title":"Metabolomics"},{"key":"10.1016\/j.ekir.2016.12.003_bib15","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.2337\/dc12-2572","article-title":"Renal structure in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function","volume":"36","author":"Ekinci","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ekir.2016.12.003_bib16","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.2337\/dc13-0298","article-title":"Long-term outcomes of Japanese type 2 diabetic patients with biopsy-proven diabetic nephropathy","volume":"36","author":"Shimizu","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ekir.2016.12.003_bib17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and progression of kidney disease in type 2 diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2016.12.003_bib18","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.cmet.2012.04.005","article-title":"Muscle-specific deletion of carnitine acetyltransferase compromises glucose tolerance and metabolic flexibility","volume":"15","author":"Muoio","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.ekir.2016.12.003_bib19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","article-title":"A\u00a0branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance","volume":"9","author":"Newgard","year":"2009","journal-title":"Cell Metab"},{"key":"10.1016\/j.ekir.2016.12.003_bib20","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/hep.26667","article-title":"Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice","volume":"59","author":"Sinha","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.ekir.2016.12.003_bib21","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/nep.12379","article-title":"Ethnic disparity in prevalence of diabetic kidney disease in an Asian primary healthcare cluster","volume":"20","author":"Loh","year":"2015","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.ekir.2016.12.003_bib22","doi-asserted-by":"publisher","first-page":"e1005553","DOI":"10.1371\/journal.pgen.1005553","article-title":"Metabolomic quantitative trait loci (mQTL) mapping implicates the ubiquitin proteasome system in cardiovascular disease pathogenesis","volume":"11","author":"Kraus","year":"2015","journal-title":"PLoS Genet"},{"key":"10.1016\/j.ekir.2016.12.003_bib23","first-page":"1073","article-title":"Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women","volume":"139","author":"Adams","year":"2009","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.ekir.2016.12.003_bib24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cmet.2007.10.013","article-title":"Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance","volume":"7","author":"Koves","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.ekir.2016.12.003_bib25","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.cmet.2012.01.024","article-title":"Interplay between lipids and branched-chain amino acids in development of insulin resistance","volume":"15","author":"Newgard","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.ekir.2016.12.003_bib26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2337\/db12-0466","article-title":"Acylcarnitines: Reflecting or inflicting insulin resistance?","volume":"62","author":"Schooneman","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.ekir.2016.12.003_bib27","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1742-4658.2010.07947.x","article-title":"Fatty acid omega-oxidation as a rescue pathway for fatty acid oxidation disorders in humans","volume":"278","author":"Wanders","year":"2011","journal-title":"FEBS J"},{"key":"10.1016\/j.ekir.2016.12.003_bib28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cccn.2004.12.020","article-title":"Identification of ethylsuccinylcarnitine present in some human urines","volume":"355","author":"Libert","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ekir.2016.12.003_bib29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11306-011-0291-6","article-title":"Discovery of early-stage biomarkers for diabetic kidney disease using MS-based metabolomics (FinnDiane study)","volume":"8","author":"van der Kloet","year":"2012","journal-title":"Metabolomics"},{"key":"10.1016\/j.ekir.2016.12.003_bib30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ics.2004.09.043","article-title":"Oxidative fuel selection: Adjusting mix and flux to stay alive","volume":"1275","author":"Weber","year":"2004","journal-title":"Int Congress Series"},{"key":"10.1016\/j.ekir.2016.12.003_bib31","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.cmet.2015.02.007","article-title":"Maximal oxidative capacity during exercise is associated with skeletal muscle fuel selection and dynamic changes in mitochondrial protein acetylation","volume":"21","author":"Overmyer","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.ekir.2016.12.003_bib32","doi-asserted-by":"publisher","first-page":"677","DOI":"10.2337\/diabetes.49.5.677","article-title":"Fuel selection in human skeletal muscle in insulin resistance: A reexamination","volume":"49","author":"Kelley","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.ekir.2016.12.003_bib33","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/nrendo.2015.129","article-title":"Acylcarnitines\u2013old actors auditioning for new roles in metabolic physiology","volume":"11","author":"McCoin","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ekir.2016.12.003_bib34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0009-8981(02)00182-1","article-title":"Strategies for the diagnosis of mitochondrial fatty acid beta-oxidation disorders","volume":"323","author":"Sim","year":"2002","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ekir.2016.12.003_bib35","doi-asserted-by":"publisher","first-page":"4888","DOI":"10.1172\/JCI66218","article-title":"AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function","volume":"123","author":"Dugan","year":"2013","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ekir.2016.12.003_bib36","doi-asserted-by":"publisher","first-page":"663","DOI":"10.2337\/db14-0874","article-title":"Mitochondrial hormesis and diabetic complications","volume":"64","author":"Sharma","year":"2015","journal-title":"Diabetes"},{"issue":"suppl 2","key":"10.1016\/j.ekir.2016.12.003_bib37","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.2337\/db06-S002","article-title":"Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction","volume":"55","author":"Morino","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.ekir.2016.12.003_bib38","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.2337\/db14-1560","article-title":"Increasing pyruvate dehydrogenase flux as a treatment for diabetic cardiomyopathy: A combined 13C hyperpolarized magnetic resonance and echocardiography study","volume":"64","author":"Le Page","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.ekir.2016.12.003_bib39","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/S0140-6736(81)90186-0","article-title":"Examination of a myopathy by phosphorus nuclear magnetic resonance","volume":"2","author":"Gadian","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2016.12.003_bib40","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1476-511X-12-98","article-title":"Role of ceramide in diabetes mellitus: Evidence and mechanisms","volume":"12","author":"Galadari","year":"2013","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.ekir.2016.12.003_bib41","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/0005-2760(82)90114-X","article-title":"The role of endogenous phosphatidylcholine and ceramide in the biosynthesis of sphingomyelin in mouse fibroblasts","volume":"710","author":"Marggraf","year":"1982","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ekir.2016.12.003_bib42","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/ki.2010.531","article-title":"Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts","volume":"80","author":"Gansevoort","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2016.12.003_bib43","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1093\/hmg\/dds138","article-title":"Validated SNPs for eGFR and their associations with albuminuria","volume":"21","author":"Ellis","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ekir.2016.12.003_bib44","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1124\/jpet.110.168815","article-title":"Role of sphingolipid mediator ceramide in obesity and renal injury in mice fed\u00a0a\u00a0high-fat diet","volume":"334","author":"Boini","year":"2010","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.ekir.2016.12.003_bib45","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/j.talanta.2011.05.036","article-title":"Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy","volume":"85","author":"Zhu","year":"2011","journal-title":"Talanta"},{"key":"10.1016\/j.ekir.2016.12.003_bib46","doi-asserted-by":"publisher","first-page":"e106631","DOI":"10.1371\/journal.pone.0106631","article-title":"A\u00a0gene variant in CERS2 is associated with rate of increase in albuminuria in patients with diabetes from ONTARGET and TRANSCEND","volume":"9","author":"Shiffman","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2016.12.003_bib47","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1681\/ASN.2007020189","article-title":"Glomerular filtration rate and albuminuria: Twin manifestations of nephropathy in diabetes","volume":"18","author":"de Boer","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024916301814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024916301814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T17:22:19Z","timestamp":1536168139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024916301814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S2468024916301814"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2016.12.003","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Profiling of Plasma Metabolites Suggests Altered Mitochondrial Fuel Usage and Remodeling of Sphingolipid Metabolism in Individuals With Type\u00a02 Diabetes and Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2016.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}